CervoMed Inc’s filing revealed that its CFO & GC ELDER WILLIAM ROBERT acquired Company’s shares for reported $18160.0 on Aug 27 ’24. In the deal valued at $18.16 per share,1,000 shares were bought. As a result of this transaction, ELDER WILLIAM ROBERT now holds 1,267 shares worth roughly $15089.97.
ROTH MKM initiated its CervoMed Inc [CRVO] rating to a Buy in a research note published on December 06, 2024; the price target was $45. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Chardan Capital Markets began covering CRVO with “Buy” recommendation on September 18, 2024. Morgan Stanley started covering the stock on July 26, 2024. It rated CRVO as “an Overweight”.
Price Performance Review of CRVO
On Friday, CervoMed Inc [NASDAQ:CRVO] saw its stock jump 22.53% to $11.91. Over the last five days, the stock has gained 10.28%. CervoMed Inc shares have risen nearly 56.09% since the year began. Nevertheless, the stocks have risen 35.34% over the past one year. While a 52-week high of $26.38 was reached on 03/20/24, a 52-week low of $5.85 was recorded on 01/02/24. SMA at 50 days reached $12.19, while 200 days put it at $16.95.
Levels Of Support And Resistance For CRVO Stock
The 24-hour chart illustrates a support level at 9.87, which if violated will result in even more drops to 7.84. On the upside, there is a resistance level at 14.17. A further resistance level may holdings at 16.44. The Relative Strength Index (RSI) on the 14-day chart is 55.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.57, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 37.44%. Stochastics %K at 46.57% indicates the stock is a holding.
How much short interest is there in CervoMed Inc?
A steep rise in short interest was recorded in CervoMed Inc stocks on 2024-11-15, growing by 0.4 million shares to a total of 1.67 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 1.27 million shares. There was a rise of 23.94%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 15, 2024 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
